Graham Bayly

Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes

Mohammad Alhadj Ali, Sefina Arif, Danijela Tatović et al. · Science Translational Medicine · 2017 · 211 citations · Full text

Whose normal thyroid function is better—yours or mine?

Colin Dayan, Ponnusamy Saravanan, Graham Bayly · The Lancet · 2002 · 59 citations

Iodine Deficiency Disorders, Thyroid Disease, Thyroid Disorders +4

Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989–2017

Alison Pottle, Gilbert R. Thompson, Mahmoud Barbir et al. · Atherosclerosis · 2019 · 33 citations

Cardiovascular Epidemiology, Health Policy, Cardiovascular Disease +7

Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network

Alberico L. Catapano, Lâle Tokgözoğlu, Maciej Banach et al. · Atherosclerosis · 2023 · 26 citations · Full text

Metabolic Syndrome, Lipid Disorder, Cardiovascular Epidemiology +10

Comparative accuracy of cardiovascular risk prediction methods in patients with diabetes mellitus

Frances L. Game, William A. Bartlett, Graham Bayly et al. · Diabetes Obesity and Metabolism · 2001 · 21 citations